3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
1228
Neoplasms
1037
Carcinoma, Non-Small-Cell Lung
757
Prostatic Neoplasms
695
Colorectal Neoplasms
597
Lung Neoplasms
578
Pancreatic Neoplasms
400
Leukemia, Myeloid, Acute
398
Neoplasm Metastasis
391
Multiple Myeloma
373
Ovarian Neoplasms
372
Stomach Neoplasms
319
Carcinoma, Hepatocellular
302
Melanoma
283
Brain Neoplasms
280
Recurrence
278
Squamous Cell Carcinoma of Head and Neck
269
Head and Neck Neoplasms
239
Glioblastoma
235
Endometrial Neoplasms
235
Triple Negative Breast Neoplasms
229
Precursor Cell Lymphoblastic Leukemia-Lymphoma
225
Lymphoma
225
Uterine Cervical Neoplasms
224
Sarcoma
202
Hematologic Neoplasms
201
Urinary Bladder Neoplasms
197
Esophageal Neoplasms
192
Carcinoma, Renal Cell
190
Lymphoma, Non-Hodgkin
177
Interventions
Radiosurgery
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Castrate Resistance Prostate Cancer
×
1 year
×
Clear all
NCT06927635
2025-09-05
SECURE
University Health Network, Toronto
Phase 2
Recruiting
75 enrolled